Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Orthop. Sep 18, 2023; 14(9): 707-719
Published online Sep 18, 2023. doi: 10.5312/wjo.v14.i9.707
Table 1 Table of participant demographics

Intervention group orthotics and orthotic sandals (%)
Control group orthotics only (%)
Both groups (%)
Sex
Male3 (6.0%)4 (8.3%)7 (7.1%)
Female47 (94.0%)44 (91.7%)91 (92.9%)
Age (year)
20-291 (2.0%)0 (0.0%)1 (1.0%)
30-394 (8.0%)10 (20.8%)14 (14.3%)
40-4921 (42.0%)13 (27.1%)34 (34.7%)
50-5920 (40.0%)18 (37.5%)38 (38.8%)
60-694 (8.0%)6 (12.5%)10 (10.2%)
70-790 (0.0%)1 (2.1%)1 (1.0%)
Mean age48.4449.1948.81
Total504898
Table 2 Table of analysis for all outcomes
Intervention group (orthotics and orthotic sandals)
Control group (orthotics only)
Between-group sig.test
Baseline3 wk6 wk3 mo6 moChangeSig.testBaseline3 wk6 wk3 mo6 moChangeSig.test
Foot pain NRS (IQR)7 (2)5 (4)4 (2)2 (3)1.5 (3)-6 (3.25)P < 0.001a8 (3)5 (3)4 (3)4 (4)3 (3)-4 (4.75)P < 0.001aP = 0.003b
Foot pain FHSQ (SD)28.48 (16.32)56.50 (20.83)66.83 (17.23)74.98 (18.51)79.98 (15.80)51.49 (25.15)P < 0.001c29.17 (19.70)49.57 (19.34)57.93 (20.23)62.79 (21.96)71.24 (18.98)42.07 (24.79)P = 0.001cP = 0.07d
Foot function FHSQ (SD)46.13 (21.47)71.5 (22.13)79.25 (17.83)82.63 (16.72)87.63 (14.86)41.50 (24.94)P < 0.001c43.10 (23.68)65.48 (21.82)71.74 (23.31)75.56 (22.80)80.73 (21.95)37.64 (26.34)P = 0.0013P = 0.46d
Symptom change GROC (IQR)1 (2)2 (2)3 (2)4 (2)2(2)P < 0.001a1 (2)1.5 (3)2 (2)3 (3)2 (3)P < 0.001aP = 0.93b